ReviewPharmaceuticals (Basel, Switzerland)2025

Pharmacogenomics of Tirzepatide: Genomic Insights into Dual GIP/GLP-1 Agonist Response in Type 2 Diabetes and Atherosclerosis.

Zihang Song et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.